Clinical Trials on Non-small-cell Lung Cancer (NSCLC) in New Zealand
Total 1790 results
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid Tumors | Non-small Cell Lung CancerUnited States, Italy, Australia, Poland, Spain
-
AbbVieTerminatedNon-small Cell Lung Cancer Stage IIIUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI); Eli Lilly and Company; OSI PharmaceuticalsCompletedStage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Bronchioloalveolar Carcinoma | Large Cell Lung CarcinomaUnited States
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung CancerSpain, United States, Belgium, France, Italy, Netherlands, United Kingdom
-
Cadila PharnmaceuticalsCompletedNon Small Cell Lung CancerIndia
-
NovoCure GmbHActive, not recruitingNSCLC | Nonsmall Cell Lung CancerUnited States, Poland, Hong Kong, China, Spain, Serbia, Croatia, France, Canada, Netherlands, Austria, Belgium, Bulgaria, Czechia, Germany, Hungary, Italy, Switzerland
-
Eli Lilly and CompanyAstraZenecaCompletedNon-small Cell Lung CancerSpain, United States, Korea, Republic of, Taiwan, France
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Innate PharmaRecruitingNon Small Cell Lung CancerFrance, United States, Greece, Hungary, Poland
-
AmgenRecruitingMTAP-null Non-Small-Cell Lung Cancer | MTAP-null Solid TumorsUnited States, Australia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell... and other conditionsUnited States
-
NantCell, Inc.TerminatedAdvanced Squamous Non-Small Cell Lung CancerUnited States
-
Eisai Inc.CompletedNon-small Cell Lung CancerCanada, United States, United Kingdom, Australia, Israel, Russian Federation, Czech Republic, France, Greece, Hungary, Poland
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedLung Non-Squamous Non-Small Cell Carcinoma | Stage IV Lung Non-Small Cell Cancer AJCC v7 | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858RUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States, Canada, Israel, Saudi Arabia
-
GlaxoSmithKlineCompletedNon-Small-Cell Lung CancerNetherlands, Finland, Taiwan, Belgium, Canada, Israel, Poland, Spain, Australia, Singapore, Latvia, Thailand, United Kingdom, Germany, Italy, China, Russian Federation, Philippines, Austria, Greece, Hungary, Denmark, France, Ukraine, Li... and more
-
ImmunityBio, Inc.Active, not recruitingNon Small Cell Lung CancerUnited States
-
Synta Pharmaceuticals Corp.CompletedNon Small Cell Lung CancerUnited States
-
CytRxTerminatedStage IV Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer With Pleural EffusionUnited States, Mexico, India, Ukraine, Bulgaria, Russian Federation
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedNon-small Cell Lung CancerUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Non-Small Cell Lung CancerUnited States
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Australia, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, China, Romania, Netherlands, Hong Kong, Austria, Belgium, Czechia, Hungary, Portugal, Greece, Germany, Ireland, Switze... and more
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
PfizerCompletedAdvanced Non-Small Cell Lung CancerIndia
-
Puma Biotechnology, Inc.CompletedHER2-mutant Non-Small Cell Lung CancerUnited States, France
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, Italy, France, Germany
-
Shanghai Henlius BiotechRecruitingNon-small Cell Lung Cancer | Locally Advanced or Metastatic Solid TumorsAustralia
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
PfizerNo longer availableNon Small Cell Lung Cancer ALK Positive or ROS1 PositiveUnited States
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
NovoCure GmbHMerck Sharp & Dohme LLCRecruiting
-
BioMarck Pharmaceuticals, Ltd.CompletedNon Small Cell Lung Cancer Stage IIIBIndia
-
Regeneron PharmaceuticalsBioNTech SERecruitingAdvanced Non-Small Cell Lung CancerUnited States, Korea, Republic of, Spain, Georgia, Taiwan, Germany, Turkey
-
Heat BiologicsTerminatedNon Small Cell Lung CancerUnited States
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CancerUnited Kingdom, Taiwan, Brazil, China, India, Korea, Republic of, Hong Kong
-
SCRI Development Innovations, LLCGenentech, Inc.Completed
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerIndia, Turkey, China, United States, Germany, Spain, Taiwan, Belgium, Korea, Republic of, France, Greece, Netherlands, United Kingdom, Australia, Canada, Brazil, Ireland, Portugal, Argentina
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
SanofiActive, not recruitingNon-squamous Non-small Cell Lung CancerBelgium, Italy, Spain, Japan, United States, France, Turkey
-
Boehringer IngelheimActive, not recruitingNeoplasms | Non-squamous, Non-Small-Cell Lung CancerUnited States, Spain, Korea, Republic of, France, Hong Kong, United Kingdom, Germany, Australia, Taiwan, Poland, Russian Federation, Ukraine
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Lung Adenocarcinoma | Recurrent Non-Small Cell Lung Carcinoma | Adenosquamous Lung Carcinoma | Bronchioloalveolar Carcinoma | Large Cell Lung Carcinoma | Squamous Cell Lung Carcinoma | Non-Small Cell Lung CarcinomaUnited States, Canada, Israel
-
Ontario Clinical Oncology Group (OCOG)Canadian Cancer Society (CCS)CompletedNon-small Cell Lung CancerCanada
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, Japan, France, Hungary, Netherlands
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
AbbVieTerminated